Genefarm, S.A.
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of metastatic prostate cancer in combination with surgical castration or with luteinizing hormone-releasing hormone (LHRH) analogues.
Dosage form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg ATC: L02BB03
-
The drug is prescribed for the treatment of patients with locally advanced prostate cancer (as monotherapy or as an adjunct to surgery or radiotherapy). It is also used in cases where surgery or other medical interventions are unacceptable.
Dosage form: tablets, film-coated
Active substance Dosage bicalutamide 150 mg ATC: L02BB03